Athira Pharma (ATHA)
(Delayed Data from NSDQ)
$0.43 USD
-0.03 (-7.44%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.45 +0.02 (4.58%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.80 |
EPS Last Quarter | -0.70 |
Last EPS Surprise | 6.67% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.57 |
Next Year | -1.43 |
EPS (TTM) | -2.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.80 | -0.39 | -2.57 | -1.43 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.80 | -0.39 | -2.57 | -1.43 |
Low Estimate | -0.80 | -0.39 | -2.57 | -1.43 |
Year ago EPS | -0.87 | -0.71 | -3.09 | -2.57 |
Year over Year Growth Est. | 8.05% | 45.07% | 16.83% | 44.36% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 1 | 0 | 1 |
Up Last 30 Days | 0 | 1 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 1 | 1 |
Down Last 7 Days | 1 | 0 | 1 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 0 |
Down Last 60 Days | 1 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.80 | -0.39 | -2.57 | -1.43 |
7 Days Ago | -0.69 | -0.53 | -2.56 | -2.97 |
30 Days Ago | -0.69 | -0.53 | -2.56 | -2.97 |
60 Days Ago | -0.78 | -0.64 | -2.79 | -3.46 |
90 Days Ago | -0.78 | -0.64 | -2.79 | -3.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.80 | -0.39 | -2.57 | -1.43 |
Zacks Consensus Estimate | -0.80 | -0.39 | -2.57 | -1.43 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.70 | -0.69 | -0.71 | -0.87 | NA |
Estimate | -0.75 | -0.80 | -0.96 | -0.87 | NA |
Difference | 0.05 | 0.11 | 0.25 | 0.00 | 0.10 |
Surprise | 6.67% | 13.75% | 26.04% | 0.00% | 11.62% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more